Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Clinical trial NCT00103389 · COMPLETED
Trial details
- NCT number
- NCT00103389
- Sponsor
- Cellxpert Biotechnology Corp.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2007-05-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.